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Scientific objectives
Chemotherapy has been an important modality of treat-
ment of NSCLC. Recent studies have shown that assess-
ment of predictive molecular markers could be helpful for
estimation of response rate to chemotherapy. The aim of
our study was to assess relation of mRNA levels of DNA
repair genes ERCC1, RRM1 and BRCA1 in surgically
resected tumor tissue in patients who received adjuvant
chemotherapy to disease free interval (DFI) and overall
survival (OS). We investigated if potential residual tumor
cells after resection reflect properties of a primary tumor
and response to chemotherapy according to level of pre-
dictive markers with the respect to current knowledge.
Technological approaches
We studied group of 90 patients with NSCLC, who had
undergone curative lung resection, 59 of them were sub-
sequently treated with adjuvant chemotherapy, DFI and
OS were evaluated only in this subgroup. Quantitative
estimation of mRNA of selected genes in paired (tumor
and control) lung tissue samples was performed by RT
real-time PCR.
Results interpretation
We found lower mRNA expression of ERCC1 (p<0.001)
and RRM1 (p=0.023) in NSCLC tumor tissue compared to
normal lung tissue. Comparing expression in histological
subtypes we recorded higher mRNA expression of ERCC1
(p=0.021), RRM1 (p=0.011) and BRCA1 (p=0.011) in ade-
nocarcinoma than in squamous cell carcinoma (SCC). The
differences in DFI and OS were found only in specific sub-
groups according to tumor type and stage. We found
longer OS in patients with adenocarcinoma with higher
expression of RRM1 mRNA (p=0.002). We found longer
OS in patients with SCC with higher expression of BRCA1
mRNA (p=0.041). In NSCLC patients of stage III, we
found longer DFI in patients with higher expression of
RRM1 (p=0.004) and ERCC1 (p=0.038).
Outlook and expert recommendations
Patients who had been treated with adjuvant chemother-
apy and had shown lower expression of repair genes had
adverse prognosis. We observed that the assessment of
DNA repair gene level in primary tumor treated by surgi-
cal resection had prognostic significance and did not pre-
dict response to adjuvant chemotherapy.
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